Published in Infect Immun on November 01, 1997
Epidemiology and clinical features of Cryptosporidium infection in immunocompromised patients. Clin Microbiol Rev (2002) 2.67
Genetic analysis of a Cryptosporidium parvum human genotype 1 isolate passaged through different host species. Infect Immun (2002) 1.28
Cryptosporidium parvum-specific mucosal immune response in C57BL/6 neonatal and gamma interferon-deficient mice: role of tumor necrosis factor alpha in protection. Infect Immun (2001) 1.19
Role of gamma interferon in chemokine expression in the ileum of mice and in a murine intestinal epithelial cell line after Cryptosporidium parvum infection. Infect Immun (2002) 1.13
The gamma interferon gene knockout mouse: a highly sensitive model for evaluation of therapeutic agents against Cryptosporidium parvum. J Clin Microbiol (1998) 1.11
Extensive polymorphism in Cryptosporidium parvum identified by multilocus microsatellite analysis. Appl Environ Microbiol (2000) 1.11
Partial recessive IFN-γR1 deficiency: genetic, immunological and clinical features of 14 patients from 11 kindreds. Hum Mol Genet (2011) 1.10
UV inactivation of Cryptosporidium hominis as measured in cell culture. Appl Environ Microbiol (2005) 1.08
The elderly and waterborne Cryptosporidium infection: gastroenteritis hospitalizations before and during the 1993 Milwaukee outbreak. Emerg Infect Dis (2003) 1.07
Cryptosporidiosis: environmental, therapeutic, and preventive challenges. Eur J Clin Microbiol Infect Dis (2010) 1.04
MyD88-dependent pathways mediate resistance to Cryptosporidium parvum infection in mice. Infect Immun (2006) 1.04
Characterization of Cryptosporidium meleagridis of human origin passaged through different host species. Infect Immun (2003) 1.02
Inactivation of Cryptosporidium parvum oocysts in fresh apple cider by UV irradiation. Appl Environ Microbiol (2002) 0.98
Intestinal immune response to human Cryptosporidium sp. infection. Infect Immun (2007) 0.93
TLR4 promotes Cryptosporidium parvum clearance in a mouse model of biliary cryptosporidiosis. J Parasitol (2011) 0.93
Human CD8(+) T cells clear Cryptosporidium parvum from infected intestinal epithelial cells. Am J Trop Med Hyg (2010) 0.92
Cooperative role of macrophages and neutrophils in host Antiprotozoan resistance in mice acutely infected with Cryptosporidium parvum. Infect Immun (2008) 0.90
Reactive nitrogen and oxygen species ameliorate experimental cryptosporidiosis in the neonatal BALB/c mouse model. Infect Immun (1999) 0.89
Serial propagation of the microsporidian Enterocytozoon bieneusi of human origin in immunocompromised rodents. Infect Immun (2006) 0.89
Intestinal CD103+ dendritic cells are key players in the innate immune control of Cryptosporidium parvum infection in neonatal mice. PLoS Pathog (2013) 0.87
Induction of murine immune responses by DNA encoding a 23-kDa antigen of Cryptosporidium parvum. Parasitol Res (2007) 0.86
Efficacy of monoclonal antibodies against defined antigens for passive immunotherapy of chronic gastrointestinal cryptosporidiosis. Antimicrob Agents Chemother (2002) 0.85
Marrow-derived CD40-positive cells are required for mice to clear Cryptosporidium parvum infection. Infect Immun (2001) 0.83
Recombinant proteins of Cryptosporidium parvum induce proliferation of mesenteric lymph node cells in infected mice. Infect Immun (2005) 0.81
Drug Development Against the Major Diarrhea-Causing Parasites of the Small Intestine, Cryptosporidium and Giardia. Front Microbiol (2015) 0.80
Induced susceptibility of host is associated with an impaired antioxidant system following infection with Cryptosporidium parvum in Se-deficient mice. PLoS One (2009) 0.79
Kinetics of Cryptosporidium parvum-specific cytokine responses in healing and nonhealing murine models of C. parvum infection. Parasitol Res (2005) 0.78
Cryptosporidiosis in rhesus macaques challenged during acute and chronic phases of SIV infection. AIDS Res Hum Retroviruses (2011) 0.78
Evidence of thymus-independent local and systemic antibody responses to Cryptosporidium parvum infection in nude mice. Infect Immun (1999) 0.77
Absence of CD40-CD40 ligand interactions in X-linked hyper-IgM syndrome does not affect differentiation of T helper cell subsets. Clin Exp Immunol (2000) 0.77
Cryptosporidium parvum isolate-dependent postinfectious jejunal hypersensitivity and mast cell accumulation in an immunocompetent rat model. Infect Immun (2009) 0.76
Mesenteric lymph node cells from neonates present a prominent IL-12 response to CpG oligodeoxynucleotide via an IL-15 feedback loop of amplification. Vet Res (2011) 0.76
Lymphoproliferative and cytokine responses to Cryptosporidium parvum in patients coinfected with C. parvum and human immunodeficiency virus. Clin Vaccine Immunol (2008) 0.75
Infection of immunocompetent mice with acid-water-pretreated Cryptosporidium parvum results in weight loss, and intestinal (structural and physiological) alterations. Parasitol Res (2007) 0.75
Bovine cryptosporidiosis: impact, host-parasite interaction and control strategies. Vet Res (2017) 0.75
An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med (1993) 18.56
Disseminated tuberculosis in interferon gamma gene-disrupted mice. J Exp Med (1993) 17.01
Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science (1993) 14.91
IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis. J Immunol (1991) 4.83
Cryptosporidiosis. Clin Microbiol Rev (1991) 4.73
Specific immunity to Listeria monocytogenes in the absence of IFN gamma. Immunity (1995) 3.54
IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. J Immunol (1995) 3.29
Experimental cryptosporidiosis in laboratory mice. Infect Immun (1982) 3.17
Cryptosporidiosis in patients infected with the human immunodeficiency virus. Clin Infect Dis (1992) 3.09
Response to influenza infection in mice with a targeted disruption in the interferon gamma gene. J Exp Med (1993) 2.88
CD4+ effector cells default to the Th2 pathway in interferon gamma-deficient mice infected with Leishmania major. J Exp Med (1994) 2.88
Persistent Cryptosporidium infection in congenitally athymic (nude) mice. Infect Immun (1984) 2.53
Cryptosporidiosis in perspective. Adv Parasitol (1988) 2.40
Effects of diarrhea associated with specific enteropathogens on the growth of children in rural Bangladesh. Pediatrics (1984) 2.37
Exacerbation of murine cutaneous leishmaniasis by adoptive transfer of parasite-specific helper T cell populations capable of mediating Leishmania major-specific delayed-type hypersensitivity. J Immunol (1984) 2.35
Infection dynamics of Cryptosporidium parvum (Apicomplexa: Cryptosporiidae) in neonatal mice (Mus musculus). J Parasitol (1986) 2.27
Chronic Cryptosporidium parvum infections in congenitally immunodeficient SCID and nude mice. J Infect Dis (1991) 2.15
Evaluation of an animal model system for cryptosporidiosis: therapeutic efficacy of paromomycin and hyperimmune bovine colostrum-immunoglobulin. Clin Diagn Lab Immunol (1994) 2.08
Synergistic impact of measles and diarrhoea on nutrition and mortality in Bangladesh. Bull World Health Organ (1981) 2.06
Infectivity and neutralization of Cryptosporidium parvum sporozoites. Infect Immun (1987) 2.04
Remission of diarrhoea due to cryptosporidiosis in an immunodeficient child treated with hyperimmune bovine colostrum. Br Med J (Clin Res Ed) (1986) 2.00
Cessation of Cryptosporidium-associated diarrhea in an acquired immunodeficiency syndrome patient after treatment with hyperimmune bovine colostrum. Gastroenterology (1990) 1.94
Cryptosporidium infection in an adult mouse model. Independent roles for IFN-gamma and CD4+ T lymphocytes in protective immunity. J Immunol (1991) 1.87
Characterization of herpes simplex virus type-1 infection and herpetic stromal keratitis development in IFN-gamma knockout mice. J Immunol (1995) 1.72
Antigens of Cryptosporidium sporozoites recognized by immune sera of infected animals and humans. J Parasitol (1988) 1.72
New mouse models for chronic Cryptosporidium infection in immunodeficient hosts. Infect Immun (1990) 1.71
Demonstration of serum antibodies to Cryptosporidium sp. in normal and immunodeficient humans with confirmed infections. J Clin Microbiol (1983) 1.69
Effects of immune colostrum and orally administered antisporozoite monoclonal antibodies on the outcome of Cryptosporidium parvum infections in neonatal mice. Infect Immun (1989) 1.65
Immune responses to Cryptosporidium muris and Cryptosporidium parvum in adult immunocompetent or immunocompromised (nude and SCID) mice. Infect Immun (1992) 1.55
Treatment with bovine hyperimmune colostrum of cryptosporidial diarrhea in AIDS patients. AIDS (1990) 1.46
Chronic cryptosporidial diarrhoea and hyperimmune cow colostrum. Lancet (1987) 1.37
Requirements for CD4+ cells and gamma interferon in resolution of established Cryptosporidium parvum infection in mice. Infect Immun (1993) 1.33
Cryptosporidium infections in inbred strains of mice. J Protozool (1992) 1.31
Gamma interferon functions in resistance to Cryptosporidium parvum infection in severe combined immunodeficient mice. Infect Immun (1993) 1.29
Monoclonal antibody immunotherapy in nude mice persistently infected with Cryptosporidium parvum. Infect Immun (1991) 1.28
Susceptibility of major histocompatibility complex (MHC) class I- and MHC class II-deficient mice to Cryptosporidium parvum infection. Infect Immun (1994) 1.27
Evaluation of a two-phase scid mouse model preconditioned with anti-interferon-gamma monoclonal antibody for drug testing against Cryptosporidium parvum. J Infect Dis (1995) 1.25
IL-12 protects immunocompetent and immunodeficient neonatal mice against infection with Cryptosporidium parvum. J Immunol (1996) 1.23
Salivary gland material from the sand fly Lutzomyia longipalpis has an inhibitory effect on macrophage function in vitro. Parasite Immunol (1993) 1.19
Cryptosporidium parvum infection in T-cell receptor (TCR)-alpha- and TCR-delta-deficient mice. Infect Immun (1996) 1.14
Cryptosporidium parvum in calves: kinetics and immunoblot analysis of specific serum and local antibody responses (immunoglobulin A [IgA], IgG, and IgM) after natural and experimental infections. Infect Immun (1992) 1.13
Anti-Cryptosporidium parvum antibodies inhibit infectivity in vitro and in vivo. Infect Immun (1993) 1.13
Mechanisms of innate and acquired resistance to Cryptosporidium parvum infection in SCID mice. Parasite Immunol (1994) 1.13
Anti-immunoglobulin E treatment decreases worm burden and egg production in Schistosoma mansoni-infected normal and interferon gamma knockout mice. J Exp Med (1994) 1.10
The role of humoral immunity in Cryptosporidium spp. infection. Studies with B cell-depleted mice. J Immunol (1990) 1.06
Major antigens of Cryptosporidium parvum recognised by serum antibodies from different infected animal species and man. Vet Parasitol (1994) 1.05
Cryptosporidial infections in SCID mice reconstituted with human or murine lymphocytes. J Protozool (1992) 1.00
Effect of spleen cell populations on resolution of Cryptosporidium parvum infection in SCID mice. Infect Immun (1994) 0.99
Bovine antibody against Cryptosporidium parvum elicits a circumsporozoite precipitate-like reaction and has immunotherapeutic effect against persistent cryptosporidiosis in SCID mice. Infect Immun (1994) 0.98
Class II major histocompatibility complex-deficient mice initially control an infection with Leishmania major but succumb to the disease. J Infect Dis (1995) 0.96
Immunological characterization of a 17-kDa antigen from Cryptosporidium parvum recognized early by mucosal IgA antibodies. FEMS Microbiol Lett (1992) 0.95
Inability of interferon-gamma and aminoguanidine to alter Cryptosporidium parvum infection in mice with severe combined immunodeficiency. J Parasitol (1994) 0.95
Proliferative responsiveness of lymphocytes from Cryptosporidium parvum-exposed mice to two separate antigen fractions from oocysts. Am J Trop Med Hyg (1993) 0.91
In vitro murine lymphocyte blastogenic responses to Cryptosporidium parvum. J Parasitol (1990) 0.90
Immunotherapy of cryptosporidiosis in immunodeficient animal models. J Protozool (1992) 0.88
In vitro proliferation and production of gamma interferon by murine CD4+ cells in response to Cryptosporidium parvum antigen. J Parasitol (1994) 0.88
Development of cellular immune functions in neonatal to weanling mice: relationship to Cryptosporidium parvum infection. J Parasitol (1996) 0.86
Identification of Cryptosporidium parvum oocyst/sporozoite antigens recognized by infected and hyperimmune lambs. Vet Parasitol (1994) 0.86
Infection dynamics and clinical features of cryptosporidiosis in SCID mice. Infect Immun (1994) 0.85
Characterization of anti-Cryptosporidium IgA antibodies in sera from immunocompetent individuals and HIV-infected patients. J Protozool (1992) 0.81
Serum antibody response in lambs naturally and experimentally infected with Cryptosporidium parvum. Vet Parasitol (1993) 0.80
Primary and secondary infections with Cryptosporidium parvum in immunosuppressed adult mice. Am J Trop Med Hyg (1996) 0.79
Effect of surface antigen-1 (SA-1) immune lymphocyte subsets and naive cell subsets in protecting scid mice from initial and persistent infection with Cryptosporidium parvum. Vet Immunol Immunopathol (1995) 0.79
Attempts to protect severe combined immunodeficient (scid) mice with antibody enriched for reactivity to Cryptosporidium parvum surface antigen-1. Vet Parasitol (1995) 0.77
Cryptosporidiosis in animals and humans. Microbiol Rev (1983) 5.66
The role of the eae gene of enterohemorrhagic Escherichia coli in intimate attachment in vitro and in a porcine model. J Clin Invest (1993) 4.11
The pathogenesis of hemorrhagic colitis caused by Escherichia coli O157:H7 in gnotobiotic piglets. J Infect Dis (1986) 3.96
Evidence for the shikimate pathway in apicomplexan parasites. Nature (1998) 3.60
Enteropathogenic Escherichia coli enteritis: evaluation of the gnotobiotic piglet as a model of human infection. Gut (1985) 3.43
Experimental cryptosporidiosis in laboratory mice. Infect Immun (1982) 3.17
Cryptosporidium: evidence for a single-species genus. Infect Immun (1980) 2.65
Seasonality in six enterically transmitted diseases and ambient temperature. Epidemiol Infect (2007) 2.59
Hafnia alvei, a probable cause of diarrhea in humans. Infect Immun (1991) 2.55
Cryptosporidiosis in hospital patients with gastroenteritis. Am J Trop Med Hyg (1983) 2.45
A randomized trial of varenicline (Chantix) for the treatment of spinocerebellar ataxia type 3. Neurology (2012) 2.34
Identification of genetic heterogeneity in the Cryptosporidium parvum ribosomal repeat. Appl Environ Microbiol (1996) 2.30
Practice parameter: therapies for essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2005) 2.16
Multilocus genotypic analysis of Cryptosporidium parvum isolates from different hosts and geographical origins. J Clin Microbiol (1998) 2.15
Genotypic and phenotypic characterization of Cryptosporidium parvum isolates from people with AIDS. J Infect Dis (1998) 2.07
A new restriction fragment length polymorphism from Cryptosporidium parvum identifies genetically heterogeneous parasite populations and genotypic changes following transmission from bovine to human hosts. Infect Immun (1997) 2.07
Remission of diarrhoea due to cryptosporidiosis in an immunodeficient child treated with hyperimmune bovine colostrum. Br Med J (Clin Res Ed) (1986) 2.00
Vomiting and diarrhea associated with cryptosporidial infection. N Engl J Med (1980) 1.99
Molecular cloning and expression of a gene encoding Cryptosporidium parvum glycoproteins gp40 and gp15. Infect Immun (2000) 1.94
Separation of Cryptosporidium species oocysts from feces by using a percoll discontinuous density gradient. J Clin Microbiol (1986) 1.86
Natural history and biology of Cryptosporidium parvum. Adv Parasitol (1998) 1.83
Inexpensive techniques for the production and maintenance of gnotobiotic piglets, calves and lambs. Aust Vet J (1980) 1.78
Prevalence of Cryptosporidium antibodies in 10 animal species. J Clin Microbiol (1981) 1.76
The relationship of clinical and academic productivity in a university hospital radiology department. AJR Am J Roentgenol (2000) 1.69
Efficacy of nitazoxanide against Cryptosporidium parvum in cell culture and in animal models. Antimicrob Agents Chemother (1998) 1.68
The pathogenesis of Yersinia enterocolitica infection in gnotobiotic piglets. J Med Microbiol (1985) 1.64
Cryptosporidium parvum infection of Caco-2 cell monolayers induces an apical monolayer defect, selectively increases transmonolayer permeability, and causes epithelial cell death. Infect Immun (1994) 1.61
Retrobulbar anesthesia and retinal vascular obstruction. Ophthalmology (1983) 1.60
Practice Parameter: treatment of nonmotor symptoms of Parkinson disease: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2010) 1.50
Intestinal parasites in patients with diarrhea and human immunodeficiency virus infection in Zimbabwe. AIDS (1999) 1.49
Animal propagation and genomic survey of a genotype 1 isolate of Cryptosporidium parvum. Mol Biochem Parasitol (2000) 1.49
Did Milwaukee experience waterborne cryptosporidiosis before the large documented outbreak in 1993? Epidemiology (1998) 1.48
Rifabutin but not clarithromycin prevents cryptosporidiosis in persons with advanced HIV infection. AIDS (2000) 1.48
Treatment with bovine hyperimmune colostrum of cryptosporidial diarrhea in AIDS patients. AIDS (1990) 1.46
Escherichia coli O157:H7 strains that express Shiga toxin (Stx) 2 alone are more neurotropic for gnotobiotic piglets than are isotypes producing only Stx1 or both Stx1 and Stx2. J Infect Dis (2000) 1.44
Chemical ablation of the gallbladder: is it feasible? J Vasc Interv Radiol (1995) 1.43
Evidence-based guideline update: treatment of essential tremor: report of the Quality Standards subcommittee of the American Academy of Neurology. Neurology (2011) 1.42
An outbreak of calf diarrhoea attributed to cryptosporidial infection. Vet Rec (1980) 1.39
Identification of an Enterocytozoon bieneusi-like microsporidian parasite in simian-immunodeficiency-virus-inoculated macaques with hepatobiliary disease. Am J Pathol (1997) 1.38
Chronic cryptosporidial diarrhoea and hyperimmune cow colostrum. Lancet (1987) 1.37
Diarrhea due to Cryptosporidium infection in artificially reared lambs. J Clin Microbiol (1981) 1.35
Experimental cryptosporidiosis in calves: clinical manifestations and pathological findings. Vet Rec (1983) 1.35
Mediation of Cryptosporidium parvum infection in vitro by mucin-like glycoproteins defined by a neutralizing monoclonal antibody. Infect Immun (2000) 1.34
Enterocolitis in piglets caused by Cryptosporidium sp. purified from calf faeces. Vet Parasitol (1982) 1.33
DNA probe analysis of diarrhoeagenic Escherichia coli: detection of EAF-positive isolates of traditional enteropathogenic E. coli serotypes among Bangladeshi paediatric diarrhoea patients. Mol Cell Probes (1992) 1.32
The seasonality of human campylobacter infection and Campylobacter isolates from fresh, retail chicken in Wales. Epidemiol Infect (2005) 1.28
Genetic analysis of a Cryptosporidium parvum human genotype 1 isolate passaged through different host species. Infect Immun (2002) 1.28
In vitro and in vivo pathogenicity of Plesiomonas shigelloides. Infect Immun (1987) 1.26
Transmission and serial propagation of Enterocytozoon bieneusi from humans and Rhesus macaques in gnotobiotic piglets. Infect Immun (1998) 1.26
Diarrhea in lambs experimentally infected with Cryptosporidium isolated from calves. Am J Vet Res (1981) 1.25
Use of passive surveillance data to study temporal and spatial variation in the incidence of giardiasis and cryptosporidiosis. Public Health Rep (2001) 1.24
Sequence polymorphism in the beta-tubulin gene reveals heterogeneous and variable population structures in Cryptosporidium parvum. Appl Environ Microbiol (1998) 1.22
Heart failure in Parkinson's disease: analysis of the United States medicare current beneficiary survey. Parkinsonism Relat Disord (2004) 1.22
A comparative study of specific gene probes and standard bioassays to identify diarrhoeagenic Escherichia coli in paediatric patients with diarrhoea in Bangladesh. J Med Microbiol (1992) 1.21
Attachment of Cryptosporidium parvum sporozoites to MDCK cells in vitro. Infect Immun (1994) 1.21
Rotavirus-associated diarrhea in rural Bangladesh: two-year study of incidence and serotype distribution. J Clin Microbiol (1991) 1.18
Construction and characterization of an isogenic slt-ii deletion mutant of enterohemorrhagic Escherichia coli. Infect Immun (1998) 1.14
The beneficial effects of weekly low-dose vitamin A supplementation on acute lower respiratory infections and diarrhea in Ecuadorian children. Pediatrics (1999) 1.13
Streptococcus durans: an unexpected enteropathogen of foals. J Infect Dis (1984) 1.13
Cryptosporidium parvum infection of human intestinal xenografts in SCID mice induces production of human tumor necrosis factor alpha and interleukin-8. Infect Immun (1998) 1.12
Parameters affecting polymerase chain reaction detection of waterborne Cryptosporidium parvum oocysts. Appl Microbiol Biotechnol (1997) 1.12
The gamma interferon gene knockout mouse: a highly sensitive model for evaluation of therapeutic agents against Cryptosporidium parvum. J Clin Microbiol (1998) 1.11
Development and application of genetic probes for detection of Enterocytozoon bieneusi in formalin-fixed stools and in intestinal biopsy specimens from infected patients. Clin Diagn Lab Immunol (1997) 1.11
Extensive polymorphism in Cryptosporidium parvum identified by multilocus microsatellite analysis. Appl Environ Microbiol (2000) 1.11
Experimental infection of piglets with cryptosporidium. Res Vet Sci (1981) 1.10
Antibody-based protection of gnotobiotic piglets infected with Escherichia coli O157:H7 against systemic complications associated with Shiga toxin 2. Infect Immun (1999) 1.10
Paromomycin and geneticin inhibit intracellular Cryptosporidium parvum without trafficking through the host cell cytoplasm: implications for drug delivery. Infect Immun (1998) 1.10
Localization of persistent Enterocytozoon bieneusi infection in normal rhesus macaques (Macaca mulatta) to the hepatobiliary tree. J Clin Microbiol (1998) 1.10
Spectrum and significance of bacteremia due to Moraxella catarrhalis. Clin Infect Dis (1995) 1.09
Microsporidiosis in South Africa: PCR detection in stool samples of HIV-positive and HIV-negative individuals and school children in Vhembe district, Limpopo Province. Trans R Soc Trop Med Hyg (2007) 1.08
Genetic markers differentiate C. parvum isolates. J Eukaryot Microbiol (1995) 1.08
Diarrhea in lambs: experimental infections with enterotoxigenic Escherichia coli, rotavirus, and Cryptosporidium sp. Infect Immun (1981) 1.08
An in vitro model of infection of human biliary epithelial cells by Cryptosporidium parvum. J Infect Dis (1997) 1.08
Attachment of Cryptosporidium parvum sporozoites to human intestinal epithelial cells. Infect Immun (1998) 1.07
Utility of intra-access pressure monitoring in detecting and correcting venous outlet stenoses prior to thrombosis. Kidney Int (1995) 1.05
Intestinal lesions in specific-pathogen-free lambs associated with a cryptosporidium from calves with diarrhea. Vet Pathol (1982) 1.05
Diarrhea in young red deer associated with infection with Cryptosporidium. J Infect Dis (1981) 1.04
Malignant biliary duct obstruction: long-term experience with Gianturco stents and combined-modality radiation therapy. Radiology (1996) 1.02
The relative importance of enteric pathogens affecting neonates of domestic animals. Adv Vet Sci Comp Med (1985) 1.01
Gel electrophoresis of rotavirus RNA derived from six different animal species. Aust J Exp Biol Med Sci (1979) 1.01
Enteroaggregative Escherichia coli infections in Bangladeshi children: clinical and microbiological features. J Diarrhoeal Dis Res (1991) 1.00
Presence of double-stranded RNAs in human and calf isolates of Cryptosporidium parvum. J Parasitol (2000) 0.98
Factors contributing to postweaning diarrhoea in a large intensive piggery. Aust Vet J (1980) 0.98
Host cell apoptosis impairs Cryptosporidium parvum development in vitro. J Parasitol (2000) 0.97
Effects of short-term zinc supplementation on cellular immunity, respiratory symptoms, and growth of malnourished Equadorian children. Eur J Clin Nutr (1996) 0.97
beta-tubulin mRNA as a marker of Cryptosporidium parvum oocyst viability. Appl Environ Microbiol (1999) 0.95
The aetiology and diagnosis of calf diarrhoea. Vet Rec (1981) 0.94
Role of a Gal/GalNAc-specific sporozoite surface lectin in Cryptosporidium parvum-host cell interaction. J Eukaryot Microbiol (1995) 0.93
The association of haemagglutination and adhesion with lipopolysaccharide of Shigella dysenteriae serotype 1. J Med Microbiol (1991) 0.93
Interleukin-1 beta (IL-1 beta), IL-1 receptor antagonist, and TNF alpha production in whole blood. J Leukoc Biol (1992) 0.93
Escherichia coli and rotavirus infections in four-week-old gnotobiotic piglets fed milk or dry food. Aust Vet J (1980) 0.93
Shigellosis in neonates and young infants. J Pediatr (1994) 0.92
A study of Cryptosporidium parvum genotypes and population structure. Mem Inst Oswaldo Cruz (1999) 0.92
The clinical manifestation and pathogenesis of enteritis associated with rotavirus and enterotoxigenic Escherichia coli infections in domestic animals. Prog Food Nutr Sci (1983) 0.92
Diarrhoea in goat kids attributed to cryptosporidium infection. Vet Rec (1982) 0.92
An ELISA for the detection of localized adherent classic enteropathogenic Escherichia coli serogroups. J Infect Dis (1991) 0.92